文献速递临床试验与 GCP真实世界研究与卫生经济

基于患者报告结局的肺癌术后症状管理模型的应用:多中心随机对照试验方案

Application of the patient-reported outcome-based postoperative symptom management model in lung cancer: a multicenter randomized controlled trial protocol.
PubMed 文献 · Trials · 2024-02-17

本研究为在中国四家医院开展的多中心、开放标签、随机、平行优效性试验,计划纳入440例肺癌患者并按1:1随机分为干预组与对照组。干预组当任一目标症状评分≥4分时接受基于患者报告结局(PRO)的症状管理建议,对照组遵循现行标准症状管理流程。研究通过微信小程序电子系统随访术后3个月内心理与生理症状,主要终点为出院后12周。

要点

  • 多中心开放标签随机平行优效性试验,在中国四家医院纳入440例肺癌患者,按1:1随机分组。
  • 干预组任一目标症状评分≥4分时接受基于PRO的症状管理建议,对照组遵循现行标准症状管理流程。
  • 采用MDASI肺癌特异性量表评估症状,EORTC QLQ-C30评估生活质量,主要终点为出院后12周。

核心结论

  • 本研究将检验基于移动社交媒体小程序的症状管理系统在术后照护中的可行性以及精神科医师协助治疗的效果,并为中长期患者症状管理提供证据。

研究设计与样本

  • 多中心、开放标签、随机、平行优效性试验,在中国四家医院开展,计划纳入440例肺癌患者,按1:1随机分配至干预组或对照组。
  • 症状管理系统为基于微信小程序的电子管理系统;所有患者通过MDASI肺癌特异性量表模块在术前1天、术后第1、3、5、7天及出院后12周内每周一次评估症状。
  • 同时使用EORTC QLQ-C30量表在基線及术后第4周和第12周评估患者生活质量。
  • 采用t检验比较干预组与对照组症状阈值事件的平均数,采用混合效应模型比较PRO的变化;主要终点设定为出院后12周。

主要发现

  • 原文为试验方案,未报告研究结果。

关键数值与推荐

  • 任一目标症状达到预设阈值(评分≥4分)时,患者接受基于PRO的症状管理建议。
  • 主要终点为出院后12周;症状评估时间点为术前1天、术后第1、3、5、7天及出院后12周内每周一次。
  • 生活质量评估时间点为基線及术后第4周和第12周。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Lung cancer is the most common cancer in China, with the highest mortality rate. Surgery is the primary treatment for early lung cancer. However, patients with lung cancer have a heavy burden of symptoms within 3 months after surgery, which seriously affects their quality of life (QOL). The symptom management model based on the patient-reported outcome (PRO) is considered the best caregiving model. The clinical evidence about the symptom management of lung cancer within 3 months after the operation is very limited. Herein, we propose a randomized controlled trial to evaluate the PRO score-based monitoring and alert system for follow-up on psychological and physiological symptoms of lung cancer patients within 3 months after surgery and further investigate the effect of intervention measures based on this PRO score-based system. METHODS AND ANALYSIS: This multicenter, open-label, randomized, parallel superiority trial will be conducted at four hospitals in China. A total of 440 lung cancer patients will be recruited in this study, who will be randomly assigned to the intervention group or the control group in a ratio of 1:1. Any of the target symptoms reaches the preset threshold (score ≥ 4), the patients will accept the symptom management advices based on the PRO. The patients in the control group will follow the current standard procedure of symptom management. The symptom management system is an electronic management system based on WeChat mini programs. All patients will be evaluated for symptoms through the lung cancer module of the MDASI lung cancer-specific scale on the day before surgery, days 1, 3, 5, and 7 after surgery, and once a week during the 12-week post-discharge period. Simultaneously, the EORTC QLQ-C30 scale will be used to evaluate patients' quality of life at baseline and the fourth and twelfth week after the surgery. The mean number of symptom threshold events of the intervention and the control groups were compared by t-test, and the changes of PRO were compared by a mixed effect model. The primary endpoint has been set as the 12-week post-discharge period. DISCUSSION: This study will test the feasibility of the symptom management system based on the mobile social media applet in postoperative caregiving and the efficacy of psychiatrist-assisted treatment and provide evidence in managing the symptoms of patients in the medium and long term. TRIALS REGISTRATION: Trials registration number: ChiCTR 2200058876, Registered 18 April 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Liang Y, Jing P, Gu Z, et al. Application of the patient-reported outcome-based postoperative symptom management model in lung cancer: a multicenter randomized controlled trial protocol. Trials. 2024. PMID: 38365704. doi:10.1186/s13063-024-07963-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。